Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
- Status
- WITHDRAWN
- Phase
- PHASE3
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
- Status
- COMPLETED
- Phase
- NA
Bevacizumab Injection for Recurrent Pterygium
- Status
- COMPLETED
- Phase
- N/A
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)
- Status
- COMPLETED
- Phase
- PHASE3
ANG1005 in Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2